# Effect of Human Urinary Kallidinogenase on Inflammatory Factors in Acute Ischemic Stroke (KIF-AIS)

> **NCT06696703** · NA · RECRUITING · sponsor: **First Affiliated Hospital of Harbin Medical University** · enrollment: 200 (estimated)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DRUG:** Human urinary kininogenase(HUK)
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06696703
- **Lead sponsor:** First Affiliated Hospital of Harbin Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-01
- **Primary completion:** 2025-12-01
- **Final completion:** 2025-12-01
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2024-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06696703

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06696703, "Effect of Human Urinary Kallidinogenase on Inflammatory Factors in Acute Ischemic Stroke (KIF-AIS)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06696703. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*